Earnings History Data for Bioventus Inc. (BVS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Bioventus Inc.

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-03-2024	PM		BVS	Bioventus Inc.	425.26	0.07	0.06	-0.06	Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M [3/12/2024 7:32 AM]	5.58	0.27 (5.07%)	6.16	0.85 (16.01%)	0.80 - 6.08	596,734	110,000	7,192
Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M [3/12/2024 7:32 AM]
07-11-2023	PM		BVS	Bioventus Inc.	301.75	0.05	0.06	0.05	Bioventus Non-GAAP EPS of $0.05 beats by $0.07, revenue of $120.8M beats by $1.8M [11/7/2023 7:42 AM]	3.60	0.0 (0.00%)	3.70	0.10 (2.92%)	0.80 - 7.51	168,782	100,000	407
Bioventus Non-GAAP EPS of $0.05 beats by $0.07, revenue of $120.8M beats by $1.8M [11/7/2023 7:42 AM]
08-08-2023	PM		BVS	Bioventus Inc.	280.99	0.14	0.03	0.10	Bioventus GAAP EPS of -$0.06 beats by $0.10, revenue of $137.1M beats by $7.87M [8/8/2023 7:37 AM]	3.89	0.49 (14.41%)	3.80	0.40 (11.76%)	0.80 - 9.24	1,187,206	170,000	15,299
Bioventus GAAP EPS of -$0.06 beats by $0.10, revenue of $137.1M beats by $7.87M [8/8/2023 7:37 AM]
16-05-2023	PM	After the close (May 16)	BVS	Bioventus Inc.	76.59	-0.26	-0.11	0.04		1.20	-0.03 (-2.44%)	1.25	0.02 (1.75%)	0.80 - 10.02	147,672	240,000	369

31-03-2023	PM	7:30 AM ET (Mar 31)	BVS	Bioventus Inc.	117.39	-0.06	0.05	0.26	Bioventus Non-GAAP EPS of -$0.06 misses by $0.11, revenue of $125.83M misses by $6.87M [3/31/2023 8:58 AM]	1.04	-0.17 (-14.14%)	1.18	-0.03 (-2.36%)	0.80 - 14.49	4,224,754	430,000	45,904
Bioventus Non-GAAP EPS of -$0.06 misses by $0.11, revenue of $125.83M misses by $6.87M [3/31/2023 8:58 AM] Bioventus amends its lenders credit agreement for financial and operational flexibility [3/31/2023 9:17 AM]
08-11-2022	PM	7:00 AM ET (Nov 8)	BVS	Bioventus Inc.	442.13	0.08	0.13	0.25	Bioventus Non-GAAP EPS of $0.08 misses by $0.04, revenue of $137.1M misses by $4.49M [11/8/2022 7:41 AM]	3.00	-4.06 (-57.51%)	7.06	0.0 (0.00%)	2.78 - 17.53	3,061,517	130,000	2,434
Bioventus Non-GAAP EPS of $0.08 misses by $0.04, revenue of $137.1M misses by $4.49M [11/8/2022 7:41 AM]
11-08-2022	PM	7:00 AM ET (Aug 11)	BVS	Bioventus Inc.	475.54	0.10	0.14	0.16	Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M [8/11/2022 7:09 AM]	8.42	-0.24 (-2.77%)	8.66	0.0 (0.00%)	6.30 - 17.53	279,860	100,000	2,147
Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M [8/11/2022 7:09 AM] Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance [Aug-11-22 07:00AM]
10-05-2022	PM	7:00 AM ET (May 10)	BVS	Bioventus Inc.	533.40	0.04	0.00	-0.02	Bioventus GAAP EPS of -$0.19, revenue of $117.29M [5/10/2022 7:10 AM]	7.95	-0.29 (-3.52%)	8.24	0.0 (0.00%)	7.79 - 19.94	300,674	227,526	521
Bioventus GAAP EPS of -$0.19, revenue of $117.29M [5/10/2022 7:10 AM] Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance [May-10-22 07:00AM] Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript [May-10-22 01:00PM]
10-03-2022	PM	7:00 AM ET (Mar 10)	BVS	Bioventus Inc.	786.37	0.26	0.20	2.32	Bioventus GAAP EPS of -$0.01 misses by $0.07, revenue of $130.4M in-line; issues FY22 guidance [3/10/2022 7:06 AM]	13.68	-0.21 (-1.51%)	13.95	0.09 (0.64%)	10.74 - 19.94	1,010	148,690	2,555
Bioventus GAAP EPS of -$0.01 misses by $0.07, revenue of $130.4M in-line; issues FY22 guidance [3/10/2022 7:06 AM] Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance [Mar-10-22 07:00AM] Bioventus Inc. (BVS) Q4 2021 Earnings Call Transcript [Mar-10-22 12:30PM]
09-11-2021	PM	Before the open (Nov 9)	BVS	Bioventus Inc.	991.44	0.25	0.13	0.00	Bioventus EPS in-line, beats on revenue [11/9/2021 7:14 AM]	16.55	-0.03 (-0.18%)	16.58	0.0 (0.00%)	10.74 - 19.94	818,364	470,000	122
Bioventus EPS in-line, beats on revenue [11/9/2021 7:14 AM] Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance [Nov-09-21 07:00AM]
10-08-2021	AH	4:05 PM ET (Aug 10)	BVS	Bioventus Inc.	867.52	0.16	0.10	0.00	Bioventus EPS beats by $0.02, beats on revenue [8/10/2021 4:24 PM]	15.25	0.16 (1.06%)	15.06	-0.03 (-0.20%)	10.74 - 19.94	131,862	260,000	500
Bioventus EPS beats by $0.02, beats on revenue [8/10/2021 4:24 PM] Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance [Aug-10-21 04:05PM] Bioventus Inc. (BVS) Q2 2021 Earnings Call Transcript [Aug-11-21 03:01AM]
12-05-2021	AH	4:05 PM ET (May 12)	BVS	Bioventus Inc.	846.70	-0.02	0.04	0.00	Bioventus EPS beats by $0.05, beats on revenue [5/12/2021 4:25 PM]	15.81	0.38 (2.46%)	16.35	0.92 (5.96%)	10.74 - 19.51	109,862	150,000	1,906
Bioventus EPS beats by $0.05, beats on revenue [5/12/2021 4:25 PM] Bioventus, Inc. Class A to Host Earnings Call [May-12-21 02:45PM] Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance [May-12-21 04:05PM]
25-03-2021	AH	After the close (Mar 25)	BVS	Bioventus Inc.	899.54	2.32	0.00	0.00	Bioventus EPS beats by $0.07, beats on revenue [3/25/2021 4:56 PM]	14.78	-1.53 (-9.38%)	16.31	0.0 (0.00%)	10.74 - 19.51	400,253	350,000	245
Bioventus EPS beats by $0.07, beats on revenue [3/25/2021 4:56 PM] Bioventus, Inc. Class A to Host Earnings Call [Mar-25-21 03:15PM] Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance [Mar-25-21 04:05PM] Bioventus 4Q Results Outperform Analysts Expectations [Mar-26-21 05:11AM]